Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 26 Show results per page	View Search Criteria \| Help With Results

Last Modified: 3/1/2000


1.		Phase III Randomized Study of Sucralfate Suspension vs Topical Vitamin E for the Treatment of Chemotherapy-Induced Mucositis

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				NCI				E-1Z93 NCI-P94-0059

Last Modified: 9/6/2005


2.		Phase III Randomized, Double-Blind, Placebo-Controlled Study of VIT-E for the Control of Hot Flushes in Menopausal Women with Prior Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				18 and over				NCI				NCCTG-959253 NCI-P95-0065

Last Modified: 10/16/2007 First Published: 8/1/1998


3.		Phase III Randomized Study of the Effect of a Diet Low in Fat and High in Soy, Fruits, Vegetables, Green Tea, Vitamin E, and Fiber on PSA Levels in Patients With Prostate Cancer (Summary Last Modified 04/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention, Treatment				Closed				18 and over				NCI				MSKCC-98014 NCI-G98-1445, NCT00003367

Last Modified: 5/21/2007 First Published: 11/1/1998


4.		Randomized Chemoprevention Study of Alpha-Tocopheral (Vitamin E) in Former and Current Smokers Receiving Isotretinoin (Summary Last Modified 04/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				18 and over				NCI				MDA-DM-97078 NCI-P98-0132, NCT00003599

Last Modified: 1/30/2007 First Published: 10/1/2000


5.		Phase III Randomized Study of Donepezil and Vitamin E in the Prevention of Cognitive Dysfunction Following Cancer Treatment That Included Prophylactic Cranial Irradiation in Patients With Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Completed				18 and over				NCI				NCCTG-N99C5 NCI-P00-0169, NCT00006349

Last Modified: 10/15/2007 First Published: 8/1/2001


6.		Phase III Randomized Study of Selenium and Vitamin E for the Prevention of Prostate Cancer (SELECT Trial)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				55 and over (50 and over for African Americans)				NCCAM, NCI				SWOG-S0000 CAN-NCIC-S0000, CALGB-S0000, ECOG-S0000, NCCAM, NCI-P00-0172, NCT00006392, S0000

Last Modified: 10/1/1988


7.		Phase III Randomized, Placebo-Controlled Study of Beta-Carotene and Vitamin E in the Prevention of Lung Cancer (Summary Last Modified 10/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Closed				50 to 69								DCPC-CPSB-10005

Last Modified: 10/1/1988


8.		Study of the Effect of Nutritional Intervention on Esophageal Cancer in Linxian, People's Republic of China (Summary Last Modified 10/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Completed				40 to 69								DCPC-CPSB-11204

Last Modified: 6/1/1991


9.		Phase III Randomized, Double-Blind Study of Multiple Vitamins at the Recommended Daily Allowance (RDA) vs Multiple Vitamins at the RDA plus High-Dose Vitamins A, B6, C, and E in Patients with Transitional Cell Carcinoma of the Bladder (Summary Last Modified 06/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				any age								WVU-11715 NCI-V91-0025

Last Modified: 12/12/2007 First Published: 1/26/2003


10.		Phase III Randomized Study of Adjuvant Isotretinoin, Interferon alfa, and Vitamin E in Patients With Stage III or IV Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				ECOG-1301 E1301, NCT00054561

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute